Ana C. Veneziani

From intensification to selection: the next challenge in advanced or recurrent endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 29, 2026

Pragmatic gynecologic cancer clinical trials: statements and roadmap from the Gynecologic Cancer InterGroup Chicago Brainstorming Meeting.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 13, 2026

Breaking BRCA apart-how important is mutation location and shape in influencing outcome?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 17, 2026

Refractory ultra-high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti-PD-L1 therapy.

Journal: Gynecologic oncology reports

Published: April 10, 2026

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: April 04, 2026

Antibody-drug conjugates and beyond in platinum-resistant ovarian cancer: A comprehensive review of emergent strategies.

Journal: Therapeutic advances in medical oncology

Published: March 11, 2026

Prognostic value of circulating tumor DNA for minimal residual disease detection in ovarian cancer: A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: January 23, 2026

Immune checkpoint inhibitors in clear cell ovarian carcinoma and mixed gynecologic clear cell cohorts: a systematic review and meta-analysis.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 17, 2025

Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective study.

Journal: Gynecologic oncology

Published: June 22, 2025

From intensification to selection: the next challenge in advanced or recurrent endometrial cancer.

From intensification to selection: the next challenge in advanced or recurrent endometrial cancer.

Pragmatic gynecologic cancer clinical trials: statements and roadmap from the Gynecologic Cancer InterGroup Chicago Brainstorming Meeting.

Pragmatic gynecologic cancer clinical trials: statements and roadmap from the Gynecologic Cancer InterGroup Chicago Brainstorming Meeting.

Breaking BRCA apart-how important is mutation location and shape in influencing outcome?

Breaking BRCA apart-how important is mutation location and shape in influencing outcome?

Refractory ultra-high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti-PD-L1 therapy.

Refractory ultra-high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti-PD-L1 therapy.

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Antibody-drug conjugates and beyond in platinum-resistant ovarian cancer: A comprehensive review of emergent strategies.

Antibody-drug conjugates and beyond in platinum-resistant ovarian cancer: A comprehensive review of emergent strategies.

Prognostic value of circulating tumor DNA for minimal residual disease detection in ovarian cancer: A systematic review and meta-analysis.

Prognostic value of circulating tumor DNA for minimal residual disease detection in ovarian cancer: A systematic review and meta-analysis.

Immune checkpoint inhibitors in clear cell ovarian carcinoma and mixed gynecologic clear cell cohorts: a systematic review and meta-analysis.

Immune checkpoint inhibitors in clear cell ovarian carcinoma and mixed gynecologic clear cell cohorts: a systematic review and meta-analysis.

Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective study.

Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective study.

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.

A Comprehensive Exploration of Agents Targeting Tumor Microenvironment: Challenges and Future Perspectives.

A Comprehensive Exploration of Agents Targeting Tumor Microenvironment: Challenges and Future Perspectives.

Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers.

Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers.